European Commission’s Pharmaceutical Strategy to Tackle Unmet Kidney Care Needs
The ISN welcomes the European Commission’s “Pharmaceutical Strategy for Europe,” released on November 25, 2020. Aspects of the strategy’s objectives are reflective of ISN’s vision of equitable access to kidney health and include: Re-thinking policies to stimulate innovation in areas of need, and patient-centered, health system-oriented pharmaceutical innovation to address long-term care settings. Investing in research and...
